Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia

MLA

Molica, Stefano, et al. “Serum BAFF (B-CELL Activating Factor Of The TNF Family) Predicts Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia.” Blood, vol. 112, no. 11, Nov. 2008, p. 4158. EBSCOhost, https://doi.org/10.1182/blood.V112.11.4158.4158.

APA

Molica, S., Vitelli, G., Cutrona, G., Digiesi, G., Mirabelli, R., Giannarelli, D., Sperduti, I., & Ferrarini, M. (2008). Serum BAFF (B-CELL Activating Factor Of The TNF Family) predicts time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia. Blood, 112(11), 4158. https://doi.org/10.1182/blood.V112.11.4158.4158

Chicago

Molica, Stefano, Gaetano Vitelli, Giovanna Cutrona, Giovanna Digiesi, Rosanna Mirabelli, Diana Giannarelli, Isabella Sperduti, and Manlio Ferrarini. 2008. “Serum BAFF (B-CELL Activating Factor Of The TNF Family) Predicts Time to First Treatment in Early B-CELL Chronic Lymphocytic Leukemia.” Blood 112 (11): 4158. doi:10.1182/blood.V112.11.4158.4158.